| Primary |
| Urinary Tract Infection |
16.1% |
| Product Used For Unknown Indication |
9.7% |
| Sinusitis |
9.7% |
| Cystitis |
6.5% |
| Hypertension |
6.5% |
| Prostatitis |
6.5% |
| Breast Infection |
3.2% |
| Ear Infection |
3.2% |
| Eyelid Infection |
3.2% |
| Furuncle |
3.2% |
| Gait Disturbance |
3.2% |
| Limb Injury |
3.2% |
| Prophylaxis |
3.2% |
| Scratch |
3.2% |
| Sinus Disorder |
3.2% |
| Skin Bacterial Infection |
3.2% |
| Skin Infection |
3.2% |
| Staphylococcal Infection |
3.2% |
| Upper Respiratory Tract Infection |
3.2% |
| Urinary Tract Disorder |
3.2% |
|
| Rash |
16.0% |
| Stevens-johnson Syndrome |
8.0% |
| Urticaria |
8.0% |
| Anaphylactic Reaction |
4.0% |
| Arthralgia |
4.0% |
| Blister |
4.0% |
| Brain Oedema |
4.0% |
| Constipation |
4.0% |
| Cough |
4.0% |
| Drug Hypersensitivity |
4.0% |
| Dyspnoea |
4.0% |
| Educational Problem |
4.0% |
| Fatigue |
4.0% |
| Headache |
4.0% |
| Hypoglycaemia |
4.0% |
| Idiosyncratic Drug Reaction |
4.0% |
| Ligament Pain |
4.0% |
| No Therapeutic Response |
4.0% |
| Oropharyngeal Pain |
4.0% |
| Pancreatitis |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
31.2% |
| Drug Abuse |
15.1% |
| Adult T-cell Lymphoma/leukaemia |
10.9% |
| Burkitt's Lymphoma |
6.0% |
| Prophylaxis |
5.2% |
| Psoriatic Arthropathy |
4.8% |
| Antifungal Prophylaxis |
3.1% |
| Mantle Cell Lymphoma |
2.9% |
| Hypertension |
2.7% |
| Pneumonia |
2.6% |
| Constipation |
2.2% |
| Rheumatoid Arthritis |
1.9% |
| Drug Use For Unknown Indication |
1.7% |
| Bacteraemia |
1.6% |
| Acquired Immunodeficiency Syndrome |
1.5% |
| Hiv Infection |
1.4% |
| Foetal Exposure During Pregnancy |
1.3% |
| Immunosuppression |
1.3% |
| Pneumocystis Jiroveci Pneumonia |
1.3% |
| Insomnia |
1.2% |
|
| Drug Hypersensitivity |
18.2% |
| Interstitial Lung Disease |
10.2% |
| Spinal Fracture |
10.2% |
| Histiocytosis Haematophagic |
6.8% |
| Infection |
6.8% |
| Eosinophilia |
4.5% |
| White Blood Cell Count Decreased |
4.5% |
| Anaphylactic Shock |
3.4% |
| Cataract |
3.4% |
| Pneumonia |
3.4% |
| Rash |
3.4% |
| Sepsis |
3.4% |
| Splenic Infarction |
3.4% |
| Thrombocytopenia |
3.4% |
| Urinary Tract Infection |
3.4% |
| Abdominal Distension |
2.3% |
| Agranulocytosis |
2.3% |
| Anaphylactic Reaction |
2.3% |
| Blood Creatine Phosphokinase Increased |
2.3% |
| Bone Marrow Failure |
2.3% |
|
| Concomitant |
| Prophylaxis |
25.0% |
| Product Used For Unknown Indication |
17.0% |
| Multiple Myeloma |
9.5% |
| Drug Use For Unknown Indication |
7.5% |
| Hypertension |
6.0% |
| Diffuse Large B-cell Lymphoma |
5.6% |
| Hiv Infection |
5.0% |
| Urinary Tract Infection |
3.1% |
| Rheumatoid Arthritis |
3.0% |
| Pain |
2.3% |
| Infection Prophylaxis |
2.0% |
| Adult T-cell Lymphoma/leukaemia |
1.9% |
| Immunosuppression |
1.9% |
| Prophylaxis Against Transplant Rejection |
1.7% |
| Constipation |
1.6% |
| Diabetes Mellitus |
1.5% |
| Pneumonia |
1.5% |
| Renal Transplant |
1.4% |
| Osteoporosis |
1.3% |
| Stem Cell Transplant |
1.3% |
|
| Vomiting |
16.1% |
| Weight Decreased |
12.2% |
| Pneumonia |
8.8% |
| Urinary Tract Infection |
8.8% |
| White Blood Cell Count Decreased |
5.5% |
| Pyrexia |
4.8% |
| Sepsis |
4.8% |
| Death |
4.2% |
| Platelet Count Decreased |
3.6% |
| Infection |
3.4% |
| Thrombocytopenia |
3.4% |
| Interstitial Lung Disease |
3.1% |
| Neutrophil Count Decreased |
3.1% |
| Pain |
2.9% |
| Renal Failure |
2.7% |
| Wound Infection Staphylococcal |
2.7% |
| Rash |
2.5% |
| Weight Increased |
2.5% |
| Wound Drainage |
2.5% |
| Nausea |
2.3% |
|
| Interacting |
| Product Used For Unknown Indication |
92.3% |
| Convulsion |
7.7% |
|
| Drug Interaction |
50.0% |
| Torsade De Pointes |
50.0% |
|
